Clinical Trials · NCT03169166

The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies

CompletedPhase 4Gonadorelin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
American University of Beirut Medical Center
Enrollment
277
Start date
Mar 2017
Locations
1 site, Lebanon
Primary endpoint
Ongoing pregnancy rate in hyper-responder women undergoing assisted reproductive technology cycles
View Gonadorelin compound reference